Quel est le prix pour Cordlife Group Limited (P8A)

Le prix pour Cordlife Group Limited (P8A) est $0.10366179

Quelle est la capitalisation boursière pour Cordlife Group Limited (P8A)

La capitalisation boursière pour Cordlife Group Limited (P8A) est $26.57M

Cordlife Group Limited (P8A) Prix et Capitalisation Boursière

Established in Singapore in 2001, Cordlife Group Limited functions as an investment holding company, delivering cord blood banking solutions across a global footprint that includes Singapore, Hong Kong, India, Malaysia, and the Philippines. Its operations are structured into two distinct divisions: Banking and Diagnostics. The Banking division is responsible for the collection, processing, storage, and analysis of vital biological samples such as cord blood, cord lining, and various tissue samples. Meanwhile, the Diagnostics division furnishes an array of diagnostic tests, encompassing genetic and metabolic screenings for newborns, pediatric vision and hearing assessments, allergen testing for children, and genetic evaluations for talent identification. Beyond these core services, Cordlife also engages in corneal lenticule banking, gut microbiome storage, and offers lifestyle-focused genetic screening for adults. The company further provides "Moms Up," a mobile application designed to supply parenting information and resources pertinent to health, wellness, and lifestyle needs. Completing its diverse portfolio, Cordlife offers medical laboratory services, marketing support, property investment, alongside specialized consulting and research and development in the medical and pharmaceutical sectors.

Prix pour P8A	L’actif B	La capitalisation boursière de B	Résultats
$20,680.31 $26.57M	NVDA	$5.301T	+19,949,691.01%
$18,078.14 $26.57M	AAPL	$4.634T	+17,439,440.13%
$16,163.04 $26.57M	GOOG	$4.143T	+15,591,988.16%
$14,003.24 $26.57M	MSFT	$3.589T	+13,508,487.01%
$11,145.83 $26.57M	AMZN	$2.857T	+10,752,012.36%

Prix pour P8A

L’actif B

La capitalisation boursière de B

Résultats

$20,680.31 $26.57M